Fall in research funding

A House of Commons debate to highlight the plight of dementia research heard how funding fell by 10% last year, despite a pledge from the government in its 2019 manifesto to double spending on such research.

Leading the special debate last week Debbie Abrahams MP, who is co-chair of the All-Party Parliamentary Group on Dementia, urged the government to use the Treasury’s spring financial statement in March to honour its “Dementia Moonshot” promise of raising public funding for research from £83 million to £166 million annually.

“We have cross-party consensus but we are still waiting for the government to bring forward this additional funding,” said Abrahams, who is a Labour MP.  “A Moonshot of investment of £800 million over the next decade could unlock private investment of £1.6 – £1.8 billion.

“We saw last year an actual fall in funding provided to dementia research from £83 million to £75 million.  This is a huge missed opportunity.”

Abrahams, whose own mother was diagnosed with dementia aged 64 and died 10 years’ later, said 85% of researchers were reporting that the pandemic had resulted in fewer research opportunities.

“I believe that research will find a cure for dementia,” she told the Commons.  “We have one of the best life sciences sectors in the world as we have seen over the last two years. They are rarely talked about but they are unsung heroes.”

Similar Posts

  • Dementia in hospital

    Alzheimer’s Society has republished its website advice on improving hospital experiences for people affected by dementia, pointing out that those with the condition spend on average four times longer in hospital following a fall than others. The blog post identifies what is keeping people in hospital for longer than necessary and suggests solutions.  Among the…

  • Diabetes drug benefit

    Type 2 diabetes is a major risk factor for dementia, but new research suggests that a drug used to treat the diabetes simultaneously reduced the risk of dementia. Scientists at Seoul University discovered that people with type 2 diabetes who were prescribed pioglitazone had a lower dementia risk compared with those who weren’t prescribed the…

  • DEEP 10th anniversary

    DEEP – the UK network of dementia voices – will be “shouting out loud and proud” this year to celebrate its 10th anniversary. There will be an online festival on 5 – 9 December with a wide range of sessions, including a mixture of fun and serious discussions, practical activities and the showcasing of DEEP…

  • Iceland says “Think Brain Health”

    The Iceland retail chain joined forces with Alzheimer’s Research UK in a “Think Brain Health” initiative to promote positive dietary choices.  Aimed at reducing dementia risk, the promotion ran in Iceland stores throughout September, highlighting fruit, vegetable and salad purchases.  Iceland said the initiative was based on the research finding that up to 40% of…

  • Statistics updated

    Alzheimer’s Society has updated its estimate of the number of people in the UK with dementia to 900,000 aged over 65.  It revises the previous figure of 850,000, which dates back to 2014, and takes into account “excess deaths” of people with dementia during the pandemic.  The new figure of 900,000 is based on modelling…